dacarbazine has been researched along with lithium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, W; Han, S; Jiang, Y; Meng, L; Tie, X; Wu, A; Xia, J | 1 |
1 other study(ies) available for dacarbazine and lithium
Article | Year |
---|---|
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.
Topics: Aged; Animals; Antibodies, Neutralizing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Fas Ligand Protein; Female; Gene Knockdown Techniques; Glioblastoma; Glycogen Synthase Kinase 3; Humans; Lithium; Male; Mice; Middle Aged; Neoplasm Transplantation; NFATC Transcription Factors; Primary Cell Culture; Protein Transport; Signal Transduction; Survival Rate; Temozolomide; Tumor Suppressor Protein p53 | 2017 |